These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 17762512

  • 1. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
    Wesołowska A, Nikiforuk A, Stachowicz K.
    Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
    [Abstract] [Full Text] [Related]

  • 2. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A.
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [Abstract] [Full Text] [Related]

  • 3. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
    Wesołowska A, Nikiforuk A, Stachowicz K.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):185-90. PubMed ID: 17097082
    [Abstract] [Full Text] [Related]

  • 4. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E.
    Neuropharmacology; 2006 Sep 28; 51(3):578-86. PubMed ID: 16828124
    [Abstract] [Full Text] [Related]

  • 5. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
    Wesołowska A.
    Eur J Pharmacol; 2008 Feb 12; 580(3):355-60. PubMed ID: 18096153
    [Abstract] [Full Text] [Related]

  • 6. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA, Hughes ZA, Starr KR, Storey JD, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan JJ, Price GW.
    Neuropharmacology; 2006 Jun 12; 50(8):975-83. PubMed ID: 16581092
    [Abstract] [Full Text] [Related]

  • 7. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E.
    J Pharm Pharmacol; 2005 Feb 12; 57(2):253-7. PubMed ID: 15720791
    [Abstract] [Full Text] [Related]

  • 8. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397
    [Abstract] [Full Text] [Related]

  • 9. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
    Kassai F, Schlumberger C, Kedves R, Pietraszek M, Jatzke C, Lendvai B, Gyertyán I, Danysz W.
    Behav Pharmacol; 2012 Aug 14; 23(4):397-406. PubMed ID: 22785385
    [Abstract] [Full Text] [Related]

  • 10. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K, Kłodzińska A, Palucha-Poniewiera A, Schann S, Neuville P, Pilc A.
    Neuropharmacology; 2009 Sep 14; 57(3):227-34. PubMed ID: 19539634
    [Abstract] [Full Text] [Related]

  • 11. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E, Paluchowska MH.
    Pol J Pharmacol; 1999 Sep 14; 51(5):405-13. PubMed ID: 10817541
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E, Treit D, Dickson CT.
    Neuroscience; 2009 Jun 30; 161(2):359-69. PubMed ID: 19321151
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G.
    Pol J Pharmacol; 1998 Jun 30; 50(2):117-24. PubMed ID: 9798263
    [Abstract] [Full Text] [Related]

  • 14. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K, Chojnacka-Wójcik E, Kłak K, Pilc A.
    Neuropharmacology; 2007 Feb 30; 52(2):306-12. PubMed ID: 17020774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
    Gravius A, Laszy J, Pietraszek M, Sághy K, Nagel J, Chambon C, Wegener N, Valastro B, Danysz W, Gyertyán I.
    Behav Pharmacol; 2011 Apr 30; 22(2):122-35. PubMed ID: 21301322
    [Abstract] [Full Text] [Related]

  • 18. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Apr 30; 54(6):615-23. PubMed ID: 12866716
    [Abstract] [Full Text] [Related]

  • 19. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
    Ghisleni G, Kazlauckas V, Both FL, Pagnussat N, Mioranzza S, Rocha JB, Souza DO, Porciúncula LO.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1508-15. PubMed ID: 18579279
    [Abstract] [Full Text] [Related]

  • 20. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
    Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A.
    Neuropharmacology; 2007 Nov 01; 53(6):741-8. PubMed ID: 17870136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.